22 August 2012, New Delhi. As directed by the Supreme Court of India on 10 July 2012, the petition filed by Novartis AG, challenging the Intellectual Property Appellate Board’s rejection of its appeal against the Indian Patent Office’s refusal to grant it a patent for the beta-crystalline form of imatinib mesylate, and related matters were…

2014 © Copyright - Lawyers Collective Designed by CGD

Current News